Author

Daniel Kwan

University of British Columbia

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Agni F. M. GavriilidouiD· 1 shared Annett PetrichiD· 1 shared Antonios KolocourisiD· 1 shared Cato MestdaghiD· 1 shared Christina Tzitzoglaki· 1 shared David FedidaiD· 1 shared F. Brent Johnson· 1 shared Francesc Xavier SuredaiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Agni F. M. GavriilidouORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Antiviral Mechanisms and Preclinical Evaluation of Amantadine Analogs that Continue to Inhibit Influenza A Viruses with M2 S31N-Based Drug Resistance

Ian Tietjen, Daniel Kwan, Annett Petrich, Roland Zell, Ivi Theodosia Antoniadou, Agni F. M. Gavriilidou, Christina Tzitzoglaki, Michail Christou Rallis, David Fedida, Francesc Xavier Sureda, Cato Mestdagh, Lieve M. J. Naesens, Salvatore Chiantia, F. Brent Johnson, Antonios Kolocouris

This study evaluates amantadine analogs against influenza A viruses with M2S31N resistance, finding some inhibit viral entry and assembly while being tolerated in mice.

Antiviral Research · Feb 11, 2025Peer-reviewedMicrobiology